[HTML][HTML] Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance
Background HER2 plays a critical role in tumourigenesis and is associated with poor
prognosis of patients with HER2-positive breast cancers. Although anti-HER2 drugs are …
prognosis of patients with HER2-positive breast cancers. Although anti-HER2 drugs are …
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance.
Q Liu, NC Borcherding, P Shao, PK Maina, W Zhang… - Ebiomedicine, 2020 - europepmc.org
Background HER2 plays a critical role in tumourigenesis and is associated with poor
prognosis of patients with HER2-positive breast cancers. Although anti-HER2 drugs are …
prognosis of patients with HER2-positive breast cancers. Although anti-HER2 drugs are …
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance
Q Liu, NC Borcherding, P Shao, PK Maina… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background HER2 plays a critical role in tumourigenesis and is associated with poor
prognosis of patients with HER2-positive breast cancers. Although anti-HER2 drugs are …
prognosis of patients with HER2-positive breast cancers. Although anti-HER2 drugs are …
[PDF][PDF] Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance
Q Liu, NC Borcherding, P Shao, PK Maina, W Zhang… - 2019 - ncborcherding.github.io
Background: HER2 plays a critical role in tumourigenesis and is associated with poor
prognosis of patients with HER2-positive breast cancers. Although anti-HER2 drugs are …
prognosis of patients with HER2-positive breast cancers. Although anti-HER2 drugs are …
[HTML][HTML] Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance
Q Liu, NC Borcherding, P Shao, PK Maina… - …, 2020 - ncbi.nlm.nih.gov
Background HER2 plays a critical role in tumourigenesis and is associated with poor
prognosis of patients with HER2-positive breast cancers. Although anti-HER2 drugs are …
prognosis of patients with HER2-positive breast cancers. Although anti-HER2 drugs are …
[HTML][HTML] Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance
Q Liu, NC Borcherding, P Shao, PK Maina, W Zhang… - EBioMedicine, 2020 - Elsevier
Background HER2 plays a critical role in tumourigenesis and is associated with poor
prognosis of patients with HER2-positive breast cancers. Although anti-HER2 drugs are …
prognosis of patients with HER2-positive breast cancers. Although anti-HER2 drugs are …